Revisión de una suspensión oral de hidralazina 4 mg/ml Review of an oral 4 mg/ml suspension of hydralizine
Main Authors: | E. Espino Paisán, M. Rodríguez-Prada, M. González Barcia |
---|---|
Format: | Article |
Language: | English |
Published: |
Arán Ediciones, S. L.
2012-02-01
|
Series: | Nutrición Hospitalaria |
Online Access: | http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0212-16112012000100045 |
Similar Items
-
Stability of 5 mg/mL Nitrendipine Oral Suspension in Syrspend® SF PH4
by: Bellay Romain, et al.
Published: (2018-03-01) -
Physicochemical Stability of 5 mg/mL Pediatric Prednisone Oral Suspension in Syrspend® SF PH4
by: Bonnaure Anne-Claire, et al.
Published: (2018-06-01) -
Riluzole 5 mg/mL oral suspension: for optimized drug delivery in amyotrophic lateral sclerosis
by: Dyer AM, et al.
Published: (2016-12-01) -
Physicochemical stability of 20 mg/mL amiodarone hydrochloride oral suspension in SyrSpend® SF PH4 (liquid)
by: Adoum Anissa, et al.
Published: (2022-06-01) -
Investigation of the Physical, Chemical and Microbiological Stability of Losartan Potassium 5 mg/mL Extemporaneous Oral Liquid Suspension
by: Lisa Foley, et al.
Published: (2021-01-01)